New owner of Bausch & Lomb eyes $800 million in cost reductions

May 29, 2013 Updated May 29, 2013 at 1:58 PM EDT

By Business First

...

New owner of Bausch & Lomb eyes $800 million in cost reductions

May 29, 2013 Updated May 29, 2013 at 1:58 PM EDT

The new owner of Bausch & Lomb Inc. is looking to make $800 million in cuts.

The Rochester Business Journal reports that Valeant Pharmaceuticals International Inc. hopes to greatly reduce the Rochester company's sales, general and administrative expenses.

Those costs -- abbreviated as SG&A -- now account for about 40 percent of Bausch & Lomb's expenses. But Valeant officials say they want SG&A to be in the range of 20 percent.

Valeant's $8.7 billion acquisition of Bausch & Lomb was announced on Monday.

To submit a comment on this article, your email address is required. We respect your privacy and your email will not be visible to others nor will it be added to any email lists.